WallStreetZenWallStreetZen

NASDAQ: ILMN
Illumina Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Illumina earnings were $825.0M for the trailing 12 months ending Jun 28, 2026, with -31.8% growth year over year. The latest ILMN earnings report on Jun 28, 2026 announced Q2 2026 earnings of $207.0M, up 54.5% from last quarter. For the last reported fiscal year 2025 ending Dec 28, 2025, ILMN reported annual earnings of $850.0M, with -169.5% growth. The next ILMN earnings date is Oct 29, 2026.

ILMN past earnings growth

How has ILMN's earnings growth performed historically?

Company
-31.82%
Industry
8.82%
Market
92.59%
ILMN's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ILMN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ILMN's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ILMN earnings history

Current Revenue
$4.5B
Current Earnings
$825.0M
Current Profit Margin
18.4%
ILMN's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ILMN Return on Equity

Current Company
31.1%
Current Industry
-27.9%
Current Market
31%
ILMN's Return on Equity (31.1%)... subscribe to Premium to read more.
High Return on Equity Performance

ILMN Return on Assets

Current Company
12.7%
Current Industry
6.1%
ILMN is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ILMN announces earnings.

ILMN Return on Capital Employed

Current Company
21.94%
Current Industry
12.3%
ILMN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ILMN vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ILMN$1.39B$825.00M+0.53%$5.40
DGX$2.22B$1.06B-10.97%$9.54
IDXX$1.62B$1.14B+10.96%$14.33
MTD$1.30B$905.61M+8.01%$44.47
LH$2.36B$1.00B-16.25%$12.17
View Top Diagnostic & Research Stocks

ILMN earnings dates

Next earnings date
Oct 29, 2026

Illumina Earnings Reports & History FAQ

What were Illumina's earnings last quarter?

On ILMN's earnings call on Jul 30, 2026, Illumina (NASDAQ: ILMN) reported Q2 2026 earnings per share (EPS) of $1.37, up 8.05% year over year. Total ILMN earnings for the quarter were $207.00 million. In the same quarter last year, Illumina's earnings per share (EPS) was $1.49.

If you're new to stock investing, here's how to buy Illumina stock.

When does Illumina report earnings?

The next ILMN earnings date is Oct 29, 2026. Add ILMN to your watchlist to be reminded of Illumina's next earnings date.

Is Illumina profitable or losing money?

As of the last Illumina earnings report, Illumina is currently profitable. Illumina's net profit (also called net income) for the twelve months ending Jun 28, 2026 was $825.00 million, a 34.42% decrease year over year.

What was ILMN's earnings growth in the past year?

As of Illumina's earnings date in Jul 30, 2026, Illumina's earnings has grown -31.82% year over year. This is 40.63 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 8.82%. ILMN earnings in the past year totalled $825.00 million.

What are Illumina's earnings expectations?

The current EPS estimate for Illumina's earnings report in Oct 29, 2026 is $1.38.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.